101140-06-1 Usage
General Description
Amentoflavone is a biologically active compound, classified as a biflavonoid, found naturally in a variety of plants, including Gingko biloba, and certain species of moss. It demonstrates a diverse range of pharmacological properties, including anti-inflammatory, anti-viral, anti-cancer, anti-diabetic, anti-oxidant, and neuroprotective effects. Amentoflavone interacts with numerous enzymes and biological systems, such as inhibiting the enzyme PDE4 and binding to GABA receptors. However, due to its low water-solubility and bioavailability, further research is required to identify efficient drug delivery systems.
Check Digit Verification of cas no
The CAS Registry Mumber 101140-06-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,1,4 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 101140-06:
(8*1)+(7*0)+(6*1)+(5*1)+(4*4)+(3*0)+(2*0)+(1*6)=41
41 % 10 = 1
So 101140-06-1 is a valid CAS Registry Number.
InChI:InChI=1/C30H18O10/c31-15-4-1-13(2-5-15)24-12-23(38)29-21(36)10-20(35)27(30(29)40-24)17-7-14(3-6-18(17)33)25-11-22(37)28-19(34)8-16(32)9-26(28)39-25/h1-12,31-36H
101140-06-1Relevant articles and documents
Preparation method of natural biflavones such as I3,II8-Biapgienin and Ridiculuflavone A
-
, (2017/08/28)
The present invention belongs to the field of new compound preparation methods and medicine research, and particularly relates to a preparation method of natural biflavones such as I3,II8-Biapgienin and Ridiculuflavone A. According to the present invention, the two compounds such as I3,II8-Biapgienin and Ridiculuflavone A are firstly synthesized, wherein I3,II8-Biapgienin has good anti-depression activity, good anti-tumor activity, good anti-oxidation activity, good anti-inflammatory activity and good anti-liver injury activity, further has inhibition activity on estrogen receptors, benzodiazepine receptors and CYP, and has broad prospects in the fields of drug development and application.